The leflunomide (LEF) is an inhibitor of dihydroorotate dehydrogenase (DHODH) that broadly used in the prevention and treatment of autoimmune disorders and allograft rejection, also approved for the treatment of rheumatoid arthritis 25. Here, DHODH is linked to rheumatoid arthritis.